Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127136761 | 12713676 | 1 | I | 20000330 | 20160904 | 20160904 | PER | US-ASTRAZENECA-2000UW01150 | ASTRAZENECA | 78.00 | YR | F | Y | 0.00000 | 20160904 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127136761 | 12713676 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | U | U | 20541 | TABLET | ||||||||
| 127136761 | 12713676 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 127136761 | 12713676 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 127136761 | 12713676 | 4 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 127136761 | 12713676 | 5 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 127136761 | 12713676 | 6 | C | MERIDIA | SIBUTRAMINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127136761 | 12713676 | 1 | Breast cancer |
| 127136761 | 12713676 | 2 | Epigastric discomfort |
| 127136761 | 12713676 | 3 | Abdominal pain upper |
| 127136761 | 12713676 | 4 | Epigastric discomfort |
| 127136761 | 12713676 | 5 | Abdominal pain upper |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127136761 | 12713676 | Blood disorder | |
| 127136761 | 12713676 | Cataract | |
| 127136761 | 12713676 | Dizziness | |
| 127136761 | 12713676 | Drug ineffective | |
| 127136761 | 12713676 | Dry mouth | |
| 127136761 | 12713676 | Gastric disorder | |
| 127136761 | 12713676 | Headache | |
| 127136761 | 12713676 | Hyperhidrosis | |
| 127136761 | 12713676 | Intentional product misuse | |
| 127136761 | 12713676 | Irritable bowel syndrome | |
| 127136761 | 12713676 | Off label use | |
| 127136761 | 12713676 | Sensitisation | |
| 127136761 | 12713676 | Thirst | |
| 127136761 | 12713676 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127136761 | 12713676 | 1 | 199902 | 0 | ||
| 127136761 | 12713676 | 2 | 201602 | 0 | ||
| 127136761 | 12713676 | 3 | 201602 | 0 |